Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
B12: Subcutaneous vs
PMC Article PMC12313605
The authors reported that in obese mice, daily AOD-9604 administration over 14 days produced significant reductions in body weight gain, decreases in adipose tissue mass, and increases in fat oxidation, with effect sizes comparable to those of full-length human growth hormone [1]
These properties allow BPC-157 to accelerate the healing of muscles, tendons, ligaments, and the gastrointestinal tract while reducing inflammation 1
Over the years, he has been successful in writing SBIR grants to the DoD, NIH, and NSF, and in 2011 received a Tibbetts Award from the Small Business Administration at the White House for commercialization of SBIR grants
